How to find and view your poster

  1. Enter your name in the “Presenting Author” field.
  2. Close the keyboard and click “Search.”
  3. Click on the “Poster Image” to view your poster in full screen.
  4. To return to the main page, close the poster window.
ILTS26-ABS-138
COMPARISON OF RADIATION DOSE BETWEEN LOW-DOSE POSTOPERATIVE AND STANDARD-DOSE
PREOPERATIVE ABDOMINAL CT IN LIVING LIVER DONORS
Sunyoung Lee:Radiology,Severance Hospital, Yonsei University College of Medicine,Seoul,Korea, Republic Of|Kyoung Won Kim:Radiology,Asan Medical Center, University of Ulsan College of Medicine,Seoul,Korea, Republic Of
ILTS26-ABS-139
COMPARING BASELINE CLAUSS FIBRINOGEN WITH TEG-6 CITRATED FUNCTIONAL FIBRINOGEN IN LIVER TRANSPLANT PATIENTS
Surpreet Grewal:Queen Elizabeth Hospital Birmingham,Birmingham,United Kingdom|James Cuell:Queen Elizabeth Hospital Birmingham,Birmingham,United Kingdom|David Gomez:Queen Elizabeth Hospital Birmingham,Birmingham,United Kingdom
ILTS26-ABS-142
LIVER TRANSPLANTATION USING OLDER DONATION AFTER CIRCULATORY DEATH GRAFTS IN THE DYNAMIC PRESERVATION ERA
Ioannis A. Ziogas:University of Colorado,Aurora,United States|Charalampos Theocharopoulos:University of Colorado,Aurora,United States|Dor Yoeli:University of Colorado,Aurora,United States|Megan Adams:University of Colorado,Aurora,United States|Dimitrios Moris:MedStar Georgetown Transplant Institute,Washington,United States|Andrew Barbas:Duke University Medical Center,Durham,United States|Martin Montenovo:Vanderbilt University Medical Center,Nashville,United States|Esteban Calderon:University of North Carolina at Chapel Hill School of Medicine,Chapel Hill,United States|Chirag Desai:University of North Carolina at Chapel Hill School of Medicine,Chapel Hill,United States|Trevor Nydam:University of Colorado,Aurora,United States|Emmanouil Giorgakis:University of North Carolina at Chapel Hill School of Medicine,Chapel Hill,United States
ILTS26-ABS-143
INCREASED USE OF OLDER DCD DONORS IN US LIVER TRANSPLANTATION
Emmanouil Giorgakis:Surgery,University of North Carolina,Chapel Hill,United States|Paulo Martins:Surgery,University of Oklahom,Oklahoma City,United States|Dimitrios Moris:Surgery,Georgetown Medstar,DC,United States|Ioannis Ziogas:Surgery,University of Colorado,Denver,United States|Esteban Calderon:Surgery,University of North Carolina,Chapel Hill,United States|Melissa Chen:Surgery,University of North Carolina,Chapel Hill,United States|Sorabh Kapoor:Surgery,University of North Carolina,Chapel Hill,United States|Amit Mathur:Surgery,Mayo Clinic Arizona,Phoenix,United States|Chirag Desai:Surgery,University of North Carolina,Chapel Hill,United States
ILTS26-ABS-145
SPATIAL QUANTITATIVE METABOLOMICS REVEALS MODALITY-DEPENDENT METABOLIC SIGNATURES DURING CLINICAL LIVER PERFUSION
Abraham den Dekker:Transplant Center,Leiden University Medical Center,Leiden,Netherlands;Department of Surgery,Leiden University Medical Center,Leiden,Netherlands|Bernard van den Berg:Department of Internal Medicine (Nephrology),Leiden University Medical Center,Leiden,Netherlands;Einthoven Laboratory of Vascular and Regenerative Medicine & The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW),Leiden University Medical Center,Leiden,Netherlands|Gangqi Wang:Department of Internal Medicine (Nephrology),Leiden University Medical Center,Leiden,Netherlands;Einthoven Laboratory of Vascular and Regenerative Medicine & The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW),Leiden University Medical Center,Leiden,Netherlands|Hwai-Ding Lam:Transplant Center,Leiden University Medical Center,Leiden,Netherlands;Department of Surgery,Leiden University Medical Center,Leiden,Netherlands|Jason Doppenberg:Transplant Center,Leiden University Medical Center,Leiden,Netherlands|Ian Alwayn:Transplant Center,Leiden University Medical Center,Leiden,Netherlands;Department of Surgery,Leiden University Medical Center,Leiden,Netherlands
ILTS26-ABS-146
SURVIVAL OUTCOME AFTER LIVER TRANSPLANTATION WITH INCIDENTAL MIXED HEPATOCELLULAR- CHOLANGIOCARCINOMA ON EXPLANT HISTOPATHOLOGY: A SYSTEMATIC REVIEW AND META-ANALYSIS
Parthiban Durairaj:HB & Liver transplantation ,leeds teaching hospital NHS trust,Leeds,United Kingdom|Vivek Upasani:HB & Liver transplantation ,leeds teaching hospital NHS trust,Leeds,United Kingdom|Dhakshinamoorthy Vijayanand:HB & Liver transplantation ,leeds teaching hospital NHS trust,Leeds,United Kingdom|Benoy I Babu:HB & Liver transplantation ,leeds teaching hospital NHS trust,Leeds,United Kingdom
ILTS26-ABS-147
A COMPARISON BETWEEN FLAVIN MONONUCLEOTIDE AND LACTATE IN THEIR ASSOCIATION WITH LIVER GRAFT OUTCOMES FOLLOWING NORMOTHERMIC REGIONAL PERFUSION
Raphaël Fischer:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States;Surgery,Erasmus Medical Center,Rotterdam,Netherlands|Claire Cywes:Mayo Clinic Alix School of Medicine,Rochester,United States|Olivia Ong:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States|Nicolas Muñoz:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States|Sardar Din:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States|Tobenna Ibeabuchi:Meharry Medical College, ,Tennessee,United States|Nadim Mahmud:Hospital of the University of Pennsylvania,Philadelphia,United States|Kelly Cederquist:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States|Georgeine Smith:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States|Stephanie Benko:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States|Chase Wehrle:Surgery,Cleveland Clinic,Cleveland,United States|Elizabeth Sonnenberg:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States|Matthew Levine:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States|Samir Abu-Gazala:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States|James Markmann:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States|Kim Olthoff:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States|Abraham Shaked:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States|Frederick Vyas:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States|Marty Sellers:Gift of Life Donor Program,Philadelphia,United States|Jeroen de Jonge:Surgery,Erasmus Medical Center,Rotterdam,Netherlands|Keyue Sun:Surgery,Cleveland Clinic,Cleveland,United States|Andrea Schlegel:Surgery,Cleveland Clinic,Cleveland,United States|Peter Abt:Surgery,Hospital of the University of Pennsylvania,Philadelphia,United States
ILTS26-ABS-150
ROLE OF SALVAGE AND/OR AB INITIO LIVER TRANSPLANTATION AFTER RESECTIONS FOR HEPATOCELLULAR CARCINOMA IN THE CURRENT SCENARIO
Laura Llado:Liver Transplantation Department,Hospital U Bellvitge,Barcelona,Spain;University of Barcelona,Barcelona,Spain|Judith Camps:Liver Transplantation Department,Hospital U Bellvitge,Barcelona,Spain|Alba Cachero:Liver Transplantation Department,Hospital U Bellvitge,Barcelona,Spain|Oriana Barrios:Liver Transplantation Department,Hospital U Bellvitge,Barcelona,Spain|Marina Vila:Liver Transplantation Department,Hospital U Bellvitge,Barcelona,Spain|Lluis Secanella:Liver Transplantation Department,Hospital U Bellvitge,Barcelona,Spain|Alberto Amador:Liver Transplantation Department,Hospital U Bellvitge,Barcelona,Spain|Kristel Mils:Liver Transplantation Department,Hospital U Bellvitge,Barcelona,Spain|Maria Sorribas:Liver Transplantation Department,Hospital U Bellvitge,Barcelona,Spain|Emilio Ramos:Liver Transplantation Department,Hospital U Bellvitge,Barcelona,Spain;University of Barcelona,Barcelona,Spain
ILTS26-ABS-768
EXPANDING LIVER TRANSPLANT ONCOLOGY IN THE UNITED KINGDOM: EARLY NATIONAL OUTCOMES FROM NON-HEPATOCELLULAR CANCER SERVICE EVALUATIONS
Abdul Rahman Hakeem:King's College Hospital,London,United Kingdom|Rhiannon Taylor:NHSBT,Bristol,United Kingdom|Varuna Aluvihare:King's College Hospital,London,United Kingdom|Anya Adair:Edinburgh Transplant Unit,Edinburgh,United Kingdom|Derek Manas:NHSBT,Bristol,United Kingdom|Tahir Shah:Queen Elizabeth Hospital,Birmingham,United Kingdom|Doug Thorburn:Royal Free Hospital,London,United Kingdom|Krishna Menon:King's College Hospital,London,United Kingdom
ILTS26-ABS-152
DEMOGRAPHY, BENCHMARKING, AND PERSONALIZED MEDICINE : THE I2 SCORE - A SIMPLE, NOVEL SCORE TO CHARACTERIZE IMMUNOSUPPRESSION INTENSITY
Baptiste Michard:Hôpitaux Universitaires de Strasbourg,Strasbourg,France|Pierre Dronsart:Hôpitaux Universitaires de Strasbourg,Strasbourg,France|Pablo Ruiz:Hospital Clinic Barcelona,Barcelona,Spain|Claire Wolf:Hôpitaux Universitaires de Strasbourg,Strasbourg,France|Nicolas Jacquinot:Hôpitaux Universitaires de Strasbourg,Strasbourg,France|Camille Besch:Hôpitaux Universitaires de Strasbourg,Strasbourg,France|Julien Vionnet:Centre Hospitalier Universitaire Vaudois,Lausanne,Switzerland|Thierry Artzner:Hôpitaux Universitaires de Strasbourg,Strasbourg,France